Xencor (XNCR) Research & Development (2013 - 2026)

Xencor (XNCR) reported Research & Development of $64.7 million for Q1 2026, up 10.4% year-over-year from $58.6 million in Q1 2025, and little changed quarter-over-quarter from $64.8 million in Q4 2025.

Xencor (XNCR) Research & Development (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Research & Development data on file, last reported at $64.7 million in Q1 2026.

  • Research & Development for Q1 2026 came in at $64.7 million, up 10.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $245.5 million (up 7.03% YoY), and the FY2025 annual result was $239.4 million, up 5.16% from the prior year.
  • Research & Development steadied at $64.7 million in Q1 2026 per XNCR's latest filing, from $64.8 million in the prior quarter.
  • Over five years, Research & Development peaked at $64.9 million in Q3 2023 and troughed at $47.1 million in Q2 2022.
  • A 5-year average of $57.9 million and a median of $58.6 million in 2025 frame the typical range for Research & Development.
  • The sharpest annual moves came in 2023 and 2024: Research & Development jumped 34.81% in 2023, then dropped 20.5% in 2024.
  • A 5-year view of Research & Development shows it stood at $51.5 million in 2022, then rose by 24.82% to $64.2 million in 2023, then declined by 20.5% to $51.1 million in 2024, then advanced by 26.97% to $64.8 million in 2025, then retreated by 0.24% to $64.7 million in 2026.
  • Business Quant data shows XNCR's Research & Development at $64.7 million in Q1 2026, $64.8 million in Q4 2025, and $54.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.32 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.66 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 626,092.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -101.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -2.30 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 1.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 357,444.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 961.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -58.00 Mn
10 Xencor 953.38 Mn 878.64 Mn - 64.67 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 64.67 Mn
Dec 31, 2025 64.82 Mn
Sep 30, 2025 54.37 Mn
Jun 30, 2025 61.67 Mn
Mar 31, 2025 58.58 Mn
Dec 31, 2024 51.06 Mn
Sep 30, 2024 58.23 Mn
Jun 30, 2024 61.53 Mn
Mar 31, 2024 56.87 Mn
Dec 31, 2023 64.22 Mn
Sep 30, 2023 64.94 Mn
Jun 30, 2023 60.06 Mn
Mar 31, 2023 64.38 Mn
Dec 31, 2022 51.45 Mn
Sep 30, 2022 53.27 Mn
Jun 30, 2022 47.08 Mn
Mar 31, 2022 47.76 Mn
Dec 31, 2021 50.99 Mn
Sep 30, 2021 50.61 Mn
Jun 30, 2021 49.50 Mn